Bu videoda Celal Şengör evrim teorisinin 18 yüzyılda nasıl yavaş yavaş geliştiğini, hangi bilim adamların katkıda bulunduğunu ve Darwin'in bunları nasıl birleştirdiğini örnekleriyle beraber çok hoş bir şekilde anlatıyor.
Profesör jeolog Celal Şengör'ün bakış açısıyla bilimin güzelliği.
Yabancı bilim insanlarının bu tip videoları vardı. Bende neden önemli Türk bilim insanlarımızın olmasın diye böyle bir çalışma yaptım. Umarım beğenirsiniz.
LG Chem, la division chimie de LG Group, a signé un partenariat de distribution exclusif pour la France et la Belgique avec Laboderm - filiale de Novomed Group spécialisée en dermatologie et médecine esthétique - pour la distribution de sa gamme YVOIRE, génération innovante de produits de comblement injectables à base d’acide hyaluronique (AH) réticulé d’origine non-animale.
La gamme YVOIRE révolutionne l’offre des produits de comblement. Sa technologie exclusive « HICE » (High Concentration Equalized) se caractérise d’un côté par un haut poids moléculaire pour un effet plus durable et une plus forte élasticité, et de l’autre par une très faible concentration d’agent réticulant BDDE (Butyl Diglycidyl Ether), garantissant plus de sécurité. Au total, sa composition résulte en des produits homogènes, faciles à injecter (fluidité et régularité) et plus résistants à la dégradation enzymatique.
La gamme se décline en trois catégories de produits (« Classic », « Volume », « Contour ») avec ou sans lidocaïne (pour plus de confort), offrant aux praticiens de larges possibilités d’interventions personnalisées selon les patients.
To view the multimedia release go to:
https://www.multivu.com/players/fr/8392651-lg-chem-laboderm-distributeur-yvoire/
Müslüman ama hadis karşıtı felsefeci Caner Taslaman ve hadislerin yılmaz savunucusu Ebubekir Sifil arasında yaşanan deve sidiği hadisi tartışması sırasında Taslaman'ın daha fazla dayanamayıp ''Madem şifa, alın için!'' deyip masaya hunharca deve sidiğ...Canlı yayınında "hadis tartışması" yapan Caner Taslaman ve Ebubekir Sifil arasında deve idrarı tartışması yaşandı. Bir hadisi çürütmeye çalışan Taslaman, ...
Caner Taslaman Masaya Deve Sidiği Koydu / Ebubekir Sifil - Caner Taslaman Tartışması Caner Taslaman ve Ebubekir Sifil arasında deve idrarı tartışması ...
Yıldız Teknik Üniversitesi Felsefe Bölümü öğretim üyesi Prof. Caner Taslaman ile Yalova Üniversitesi İlahiyat Fakültesi öğretim üyesi Yrd. Doç. Dr. Ebubekir Sifil ...
Ahmet Çam ahmet çam Ahmet çam ahmet Çam Ahmet Çam Kısa film Ebubekir Sifil Caner Taslaman HaberTürk deve sidiği tartışması Deve sidiği cübbeli ahmet ...
Habertürk TV'de Veyis Ateş'in sunduğu programda Caner Taslaman ile İlahiyatçı Ebubekir Sifil hadislerin kaynağı ve güvenilirliğini tartıştı. Hadislerin bir ...
C. R. Bard, Inc. today announced the publication of RESILIENT trial results by Circulation: Cardiovascular Interventions showing the Bard LifeStent® Vascular Stent improved patency and reduced revascularization rates in patients with moderate-length lesions in the superficial femoral artery (SFA) and proximal popliteal artery compared to patients treated with percutaneous transluminal angioplasty (PTA).
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/bard/44623/
One of every ten euros of the gross domestic product is gained through health care. And, despite Germanys image of being a nation of motorists actually the most patents are filed in the medical field. It is therefore no wonder that German Chancellor Angela Merkel paid a visit to the world's largest medical trade fair MEDICA in Duesseldorf. Also present was the Minister of health Dr. Philipp Rösler, who prepared for the upcoming tasks at the Hospital day which runs parallel to the fair.
Dr. Ing. h.c. F. Porsche AG, Stuttgart, is continuing to extend its performance and high efficiency competence via intensive development work in the field of hybrid technology. With the Porsche 918 RSR, the manufacturer of sporty premium vehicles is presenting a high-end synthesis of 2010's successful hybrid concepts. The two-seater mid-engine coupé 918 RSR clearly reveals what happens when the technology fitted in the 911 GT3 R hybrid and the design of the 918 Spyder are transferred to a modern, innovative super sports car.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/porsche/47949/
Am 20. Mai 2011 wurde der Politiker und Ex-Finanzminister Peer Steinbrück in Bonn mit dem Cicero Rednerpreis 2011 ausgezeichnet. Der Cicero Rednerpreis wird vom Verlag für die Deutsche Wirtschaft seit 1994 für herausragende rhetorische Leistungen verliehen. Eine unabhängige Jury ermittelt jährlich den Preisträger. Peer Steinbrück gilt nach Meinung der Jury als streitbarer Redner mit der besonderen Fähigkeit, Reden und Handeln in Einklang zu bringen. Er ist immer wieder als möglicher Kanzlerkandidat der SPD bei der Bundestagswahl im Jahr 2013 im Gespräch.
Weitere Infos unter: www.cicero-rednerpreis.de
In the face of the most perilous challenges of our time the nations of the world seem paralyzed. The problems are too big, too interdependent, too divisive for the nation-state. Benjamin R. Barber demonstrates how city mayors, singly and jointly, are responding to transnational problems more effectively than nation-states mired in ideological infighting and sovereign rivalries. Featuring profiles of a dozen mayors around the world. If Mayors Ruled the World presents a compelling new vision of governance for the coming century. Barber makes a persuasive case that the city is democracy’s best hope in a globalizing world, and great mayors are already proving that this is so. Learn more about this book here, http://bit.ly/1ehalk2 Political
St. Jude Children’s Research Hospital, www.stjude.org, announced today the appointment of James R. Downing, M.D., as its new CEO, effective July 15, 2014. Downing most recently has served as the Deputy Director, Executive Vice President and Scientific Director of the hospital, which is leading the way the world understands, treats and defeats pediatric cancer and other catastrophic diseases. Downing’s primary focus immediately upon assuming the CEO office will be to oversee a new era of clinical, research and infrastructure expansion throughout the St. Jude global network. He succeeds Dr. William E. Evans, who is retiring from the position after 10 years and returning full time to his long-standing pharmacogenomics research program at St. Jude.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7256651-st-jude-children-s-research-hospital-new-era-of-expansion-and-growth/
